Bendamustine

Bendamustine is a chemotherapy medication that belongs to a class of drugs known as alkylating agents. It is used to treat various types of cancer, including chronic lymphocytic leukemia (CLL), indolent non-Hodgkin’s lymphoma (NHL), and multiple myeloma. Bendamustine works by interfering with the DNA replication process in cancer cells, ultimately leading to cell death. The medication is typically administered intravenously, and its use may be accompanied by other treatments, such as corticosteroids or rituximab, to enhance its effectiveness. Bendamustine can cause side effects, including fatigue, nausea, vomiting, and a decrease in blood cell counts, which may increase the risk of infections or bleeding. It is important for patients to discuss potential side effects and precautions with their healthcare provider before starting treatment with bendamustine.